Literature DB >> 23235557

Commentary: HIV testing in low- and middle-income countries: an urgent need for scaling up.

Christian Laurent1.   

Abstract

How can national AIDS program managers in low- and middle-income countries improve the coverage of HIV testing? In these countries heavily affected by HIV/AIDS, testing for HIV infection remains indeed critically infrequent with regard to its central role for individual care and control of the epidemic. Only 20 per cent of adults and 28 per cent of infants born from HIV-infected mothers are tested in a timely manner. The expansion of HIV testing is a prerequisite for reaching the World Health Organization's objective of universal access to HIV prevention, treatment, care, and support as well as the Millennium Development Goals related to HIV/AIDS and child mortality. The successful Rwandan experience of scaling up early infant HIV diagnosis brings hope for many countries.

Entities:  

Mesh:

Year:  2012        PMID: 23235557     DOI: 10.1057/jphp.2012.67

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  3 in total

1.  Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa.

Authors:  Ritu Shrivastava; Renuka Gadde; John N Nkengasong
Journal:  J Infect Dis       Date:  2016-04-15       Impact factor: 5.226

2.  The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.

Authors:  Pauline Penot; Arsène Héma; Guillaume Bado; Firmin Kaboré; Ibrahim Soré; Diamasso Sombié; Jean-Richard Traoré; Jean-Baptiste Guiard-Schmid; Arnaud Fontanet; Laurence Slama; Adrien Bruno Sawadogo; Christian Laurent
Journal:  J Int AIDS Soc       Date:  2014-01-15       Impact factor: 5.396

3.  Factors affecting HIV counselling and testing among Ethiopian women aged 15-49.

Authors:  Asfaw Negero Erena; Guanxin Shen; Ping Lei
Journal:  BMC Infect Dis       Date:  2019-12-21       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.